Sentence examples for active oncology from inspiring English sources

Hospitals with active oncology units have a higher accrual rate in cancer RCTs than other community hospitals (Mccusker et al, 1982).

Although this book is aimed at palliative care, many of the chapters offer valuable information applicable to patients undergoing active surgical or oncology treatment.

Increasingly there is a trend towards providing palliative care to those who might still be considering active treatments from oncology services to improve symptom control [ 3, 4].

This drug is certainly one of the most active drugs in oncology in the last decades and deserves registration for this indication in our opinion.

The control group was collected through the clinical specialists participating in the study and included women undergoing regular prophylactic breast examinations in the University Hospital "Alexandrovska", Medical University of Sofia, and Specialized Hospital for Active Treatment in Oncology, Sofia.

In the present study 200 unrelated female patients with primary BC, were selected from the Departments of Surgery and General and Clinical Pathology, University Hospital, "Alexandrovska", Medical University of Sofia, and the Clinic of Medical Oncology, Specialized Hospital for Active Treatment in Oncology, Sofia, during their treatment and follow up procedures for the period of 2007 2012.

MEK inhibition is an active focus of oncology research, but less attention has been paid to its role in acute and chronic inflammation, despite the important role of MEK/ERK1/2 signals in the induction and resolution of inflammation (Chappell et al, 2011).

The taxanes are among the most active cytotoxic agents in oncology and are widely used in adjuvant and advanced treatment settings in multiple tumor types.

An IC process was developed that utilizes a specialized IC team, active communication with the oncology team, and an emphasis on scheduling flexibility.

PARPi are an area of active clinical investigation in oncology as they (1) exploit synthetic lethality in tumours with defective homologous recombination (HR) and (2) potentiate the cytotoxic effect of chemotherapy and radiation.

Not surprisingly, then, drugs that modulate the activities of HATs or HDACs or, most recently, that block acetyl-lysine:BRD interactions are under active development in the oncology field.